SCHEMBL7204076

SCHEMBL7204076

CCCCCCCCCCCCCCC(CCC)(C(=O)OCC)C(=O)OCC

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
MAPT P10636 1/20 0.56
ATM Q13315 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
CYP4F2 P78329 2/20 0.49
CYP4A11 Q02928 2/20 0.49
HTT P42858 1/20 0.47
THRB P10828 1/20 0.44
PKM P14618 1/20 0.44
CES2 O00748 1/20 0.40
NAAA Q02083 1/20 0.38
DGKA P23743 1/20 0.38
GGPS1 O95749 1/20 0.38
SMPD1 P17405 1/20 0.38
FAAH O00519 2/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
FDPS P14324 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779105 1.00 MEN1 (0.56) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL8216269 0.96 MEN1 (0.59) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL11065218 0.96 MEN1 (0.59) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL11068420 0.96 MEN1 (0.59) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL11001712 0.96 MEN1 (0.59) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL11063113 0.96 MEN1 (0.59) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL21046041 0.96 MEN1 (0.59) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL183166 0.96 MEN1 (0.59) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL7516322 0.96 MEN1 (0.59) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL7516454 0.96 MEN1 (0.59) MEN1KMT2AMAPTATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102701945-A Synthetic preparation method of scheelite flotation collector ZIJIN MINING GROUP CO LTD 2012-10-03 CN disclosed
US-6605638-B1 Treating multidrug resistant tumors; increasing drug bioavailability D-PHARM LIMITED (IL) 2003-08-12 US disclosed
US-6319952-B1 EXPOSING THE MEMBRANE TO BRANCHED FATTY ACIDS OR THEIR SALTS, ESTERS OR AMIDES WHICH IMPROVE AND ENABLE THE PENETRATION AND ABSORPTION OF ACTIVE INGREDIENTS THROUGH BIOMEMBRANES D-PHARM LTD. (IL) 2001-11-20 US disclosed
EP-1007506-A2 COMPOSITIONS AND METHODS FOR REVERSIBLY INCREASING PERMEABILITY OF BIOMEMBRANES D-PHARM, LTD. (IL) 2000-06-14 EP disclosed
WO-1999002120-A2 COMPOSITIONS AND METHODS FOR REVERSIBLY INCREASING PERMEABILITY OF BIOMEMBRANES D-PHARM LTD. (IL) 1999-01-21 WO disclosed